George Kannourakis

Ballarat, VIC 3350, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma.

Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma.

Journal: Cancers

Published: April 28, 2026

The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma.

The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma.

Journal: Cells

Published: April 09, 2026

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion.

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion.

Journal: Journal of biomedical science

Published: March 05, 2026

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Journal: American journal of hematology

Published: January 30, 2026

Correlation of Galectin Family Expression with Glioblastoma Progression and Survival.

Correlation of Galectin Family Expression with Glioblastoma Progression and Survival.

Journal: International journal of molecular sciences

Published: August 28, 2025

Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment.

Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment.

Journal: Cells

Published: March 15, 2025

The Role of TIM-3 in Glioblastoma Progression.

The Role of TIM-3 in Glioblastoma Progression.

Journal: Cells

Published: January 28, 2025

Impact of Ligand Concentration on the Properties of Nucleic-Acid-Encapsulated MOFs and Inflammation Modulation in Prostate Cancer Cells.

Impact of Ligand Concentration on the Properties of Nucleic-Acid-Encapsulated MOFs and Inflammation Modulation in Prostate Cancer Cells.

Journal: ACS applied bio materials

Published: November 05, 2024

Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets.

Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets.

Journal: Cancers

Published: October 23, 2024

Advances in CRISPR/Cas systems-based cell and gene therapy.

Advances in CRISPR/Cas systems-based cell and gene therapy.

Journal: Progress in molecular biology and translational science

Published: September 12, 2024

Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation.

Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation.

Journal: Cells

Published: August 22, 2024

Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells.

Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells.

Journal: Science (New York, N.Y.)

Published: November 30, 2023

Showing 1-12 of 59

Last Updated: 09/26/2026